Onesource Specialty Pharma
Current Price
₹1,532
1 Year At A Glance - ₹10,000 invested a year ago would be worth ₹8,260 today
1Y Return
-17.40%
Trend
Bearish ↘
Vs NIFTY
Behind NIFTY ✗
Curious how ₹10,000 would have grown?
Explore returns, wealth creation, benchmark performance and similar stocks across different time periods.
Last 7 Sessions
Weekly Price Action
Fri, 21 Aug
₹1,535
Mon, 24 Aug
₹1,532
▼ 0.21%
Tue, 25 Aug
₹1,516
▼ 1.02%
Wed, 26 Aug
₹1,484
▼ 2.14%
Thu, 27 Aug
₹1,518
▲ 2.28%
Fri, 28 Aug
₹1,532
▲ 0.97%
Weekly Movement
Bearish ↘
Historical Performance
Price Evolution
Explore how the stock price evolved across different investment horizons.
Selected Period
1 Month
Return
Started At
₹1,619.7
Current Price
₹1,532.2
Analysis Period
Explore Different Time Horizons
Switch between periods to see how returns, benchmark performance and peer comparisons change over time.
Investment Journey
How ₹10,000 Changed Over 1 Year
This simulation shows how long-term investors experienced wealth creation through market movements and compounding.
Final Portfolio Value
₹8,260
-17.4%
Invested Amount
₹10,000
Profit / Loss
-₹1,740
CAGR
-17.4%
Benchmark Comparison
₹10,000 Investment Comparison (1 Year)
Compare how the same ₹10,000 investment would have performed in this stock versus NIFTY50.
₹10,000 In This Stock
₹8,260
-17.4% CAGR
₹10,000 In NIFTY50
₹9,867
-1.3% CAGR
Wealth Difference
-16.3%
This stock created less wealth than investing in NIFTY50 over the selected period.
Sector Discovery
Top 1Y Sector Performers
Compare this stock with other wealth creators in the same sector.
Laurus Labs
Return
+125.29%
Sai Life Sciences
Return
+81.97%
Granules India
Return
+79.43%
Neuland Laboratories
Return
+77.26%
Aurobindo Pharma
Return
+60.31%
Gland Pharma
Return
+54.22%
Divi's Laboratories
Return
+51.29%
J.B. Chemicals & Pharmaceuticals
Return
+44.73%
Ajanta Pharmaceuticals
Return
+44.71%
Torrent Pharmaceuticals
Return
+42.43%
Sector Discovery
Stocks With Similar 1Y CAGR
Discover stocks that generated returns similar to this company.
Colgate Palmolive (India)
Return
-17.42%
Aavas Financiers
Return
-17.29%
Poly Medicure
Return
-17.20%
Page Industries
Return
-17.16%
Suzlon Energy
Return
-16.92%
Birlasoft
Return
-16.89%
ICICI Prudential Life Insurance Company
Return
-16.70%
DCM Shriram
Return
-16.59%
Indian Renewable Energy Development Agency
Return
-16.58%
Varun Beverages
Return
-16.54%
Stock DNA
How this stock actually behaved
Four measurements taken from the same 1 year of price history shown above — how fast it grew, how often it rose, how far it fell, and how it fared against the index. Each one is stated with the number behind it so you can check the working.
Overall
The plain average of the 4 measurements below. It describes what already happened. It is not a rating, a recommendation, or a forecast.
-17.4% a year
Compounded at -17.4% annually over 1 year. The scale reaches 10 at 25% a year.
6 of 12 months up
Finished higher than the previous month in 6 of 12 months. The score is that ratio, nothing else.
−36.9% worst fall
Fell 36.9% from a previous month-end peak at its worst. Measured on month-end values, so deeper falls within a month are not captured.
-16.1pp a year
Trailed the NIFTY 50 by 16.1 percentage points a year over 1 year. A score of 5 means it matched the index.
Every scale used here is published on our Methodology page.
Explore ONESOURCE Further
Go deeper on Onesource Specialty Pharma Ltd. — year-by-year returns, head-to-head comparisons, and how the whole sector performed.
ONESOURCE Returns by Period
Invest Monthly
What ₹10,000 a month into ONESOURCE would have become, how much of its return came from dividends, every holding period on record, and how far it sits below its all-time high.
Investor Questions
Things Investors Usually Ask About ONESOURCE
Quick answers to the most important questions investors consider before researching a stock.
Onesource Specialty Pharma Ltd. compounded at approximately -17.4% a year over the last 1 year. CAGR is the steady annual rate that would produce the same result, so it can be compared directly against other stocks and against the index.
₹10,000 invested in Onesource Specialty Pharma Ltd. would have grown to approximately ₹8,260 over the analysed period, based on historical adjusted closing prices. That is a total return — dividends and stock splits are included — before brokerage and taxes.
We hold 1 year of usable daily price history for Onesource Specialty Pharma Ltd., and every figure on this page is measured within that window. Usable history can be shorter than the time a company has been listed: where our price source has a break we cannot verify — an unadjusted split, or a stretch of repeated closes — we cut the series back to after that break rather than publish a long-run number we do not trust.
The two are measured on different price series, on purpose. Returns and wealth figures use closing prices adjusted for dividends and splits, so dividends count as reinvested. The prices displayed are the raw quoted closes, so you can check them against your broker or the exchange. For a dividend payer the end price divided by the start price will therefore not reproduce the return figure — that gap is the dividends.
Past performance does not predict future returns. Valuation, revenue and earnings growth, balance-sheet quality, sector outlook and competitive position all matter, and none of them are visible in a return figure. ReturnScreener publishes the historical record only — it does not evaluate any of those things.
How This Is Calculated
Reading these figures properly
Total return, before costs
Returns and wealth figures use closing prices adjusted for dividends and splits, so dividends are treated as reinvested. Demergers are not credited, and brokerage and taxes are not modelled. The prices shown alongside are the raw quoted closes, so they can be checked against your broker.
The start date decides the answer
Every CAGR here is measured between two dates. A different starting year can move it substantially, which is why this page reports several horizons rather than one headline number.
Survivors only
Onesource Specialty Pharma Ltd.is in today's Nifty 500 universe. Companies that delisted or collapsed are not on this site at all — a bias worth holding in mind when reading any long-run historical figure.
Measured on data to 31 Aug 2026. Full definitions are on our methodology page.
ReturnScreener is an educational research platform and is not a SEBI-registered investment adviser. Everything on this page is a record of what historical prices did, not a projection and not a recommendation. Past performance does not guarantee future returns. See our methodology and disclaimer.